AI-based clinical documentation improvement is one of the fastest-growing categories in healthcare AI — 43% adoption, growing 59% year-over-year, close behind ambient note-taking itself. That growth rate reflects a real, well-earned enthusiasm: AI genuinely helps produce more complete, better-structured clinical documentation, faster, which matters for both care quality and downstream billing accuracy. The open question, growing at almost the same rate as adoption itself, is whether the review processes that catch documentation errors have scaled at the same pace as the documentation volume they now need to check.

Why documentation accuracy review is a different problem at scale

A single clinician reviewing AI-drafted documentation for their own patients, in a low-volume pilot, can reasonably catch most errors — they know the patient, they know the encounter, and the volume is manageable. That review model doesn’t automatically scale to 43% adoption across an entire health system. At scale, documentation review needs its own defined process: who reviews what, on what sampling basis, against what specific error categories, and what happens when a pattern of errors emerges rather than an isolated one.

This matters because AI documentation errors don’t fail the same way human documentation errors do. A rushed clinician’s documentation error is usually an omission — something left out under time pressure. An AI documentation error is more often a confident-sounding inclusion — a plausible-seeming detail that wasn’t quite said, or was said about a different point in the conversation than the note implies. That failure mode is specifically harder to catch in a fast skim, because it doesn’t look incomplete. It looks normal.

What a scaled review process actually needs

Three elements distinguish documentation review processes that hold up at scale from ones that quietly degrade as volume grows. A defined sampling methodology — not “spot check occasionally,” but a specific, consistent percentage or trigger-based review rule, so review effort tracks with actual risk rather than reviewer availability. A named error taxonomy — categorizing the kinds of mistakes the AI system tends to make, because a documentation review process that treats every error as a one-off misses the patterns that would otherwise flag a systemic issue with the tool or its integration. And a feedback loop back to the tool or the workflow — because a review process that catches errors without feeding that information back to reduce their recurrence is treading water rather than improving.

The billing dimension makes this more than a quality issue

Documentation accuracy isn’t only a clinical quality question in this context — it’s directly tied to coding and billing accuracy, which is itself growing as an AI application (36% adoption, 29% YoY growth in AI coding solutions). An AI documentation error that flows uncaught into AI-assisted coding compounds rather than staying isolated, which is a specific reason documentation review deserves more structure now, while adoption is still accelerating, rather than after volume has made informal review unworkable.

A direct question worth answering now

For health systems currently scaling AI clinical documentation: has the review process been redesigned for the current volume, or is it still operating on the assumptions of the original small-scale pilot? If it’s the latter, that’s a specific, closeable gap — and closing it now, while adoption is still accelerating rather than already at full scale, is meaningfully cheaper than closing it after a billing or clinical accuracy issue forces the question.

SPAR builds documentation review processes as part of the AI deployment itself, sized for the volume the rollout is heading toward rather than the volume it started at. If your documentation AI has scaled faster than your review process has, that’s worth addressing before the gap widens further.